“COMPARATIVE IMMUNE MICROENVIRONMENT PROFILING IN HBV-, HCV-, AND DUAL-INFECTED HEPATOCELLULAR CARCINOMA: TOWARD ETIOLOGY-SPECIFIC IMMUNOTHERAPEUTIC TARGETS”. 2025. Frontier in Medical and Health Research 3 (4): 843-45. https://fmhr.net/index.php/fmhr/article/view/478.